DrugPatentWatch Database Preview
Details for Patent: 7,838,027
Email this page to a colleague
Which drugs does patent 7,838,027 protect, and when does it expire?
Patent 7,838,027 protects PROTONIX and is included in one NDA.
Protection for PROTONIX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-five patent family members in twenty-eight countries.
Summary for Patent: 7,838,027
| Title: | Pantoprazole multiparticulate formulations |
| Abstract: | Pantoprazole sodium multiparticulates are described which avoid sticking to nasogastric and gastronomy tubes. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof, or a salt thereof, a surfactant, and a disintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose (hypromellose) and water, an enteric coat on the sub-coat, and a final seal coat over the enteric coat, which is composed of hydroxypropyl methylcellulose (hypromellose) and water. |
| Inventor(s): | Venkata Ramana Rao; Sripriya (Iselin, NJ), Shah; Syed M. (East Hanover, NJ), Tatapudy; Hanumantharao (Suffern, NY), Saunders; Richard William (Palisades, NY), Fawzi; Mahdi (Morristown, NJ), Nagi; Arwinder (Thiells, NY), Singh; Shailesh (Bardonia, NY), Hasan; Sumon A. (Monroe, NY) |
| Assignee: | Wyeth LLC (Madison, NJ) |
| Application Number: | 10/574,210 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; Use; Formulation; |
Drugs Protected by US Patent 7,838,027
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms | PROTONIX | pantoprazole sodium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022020-001 | Nov 14, 2007 | AB | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | Y | ⤷ Free Forever Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,838,027
| PCT Information | |||
| PCT Filed | September 30, 2004 | PCT Application Number: | PCT/US2004/033058 |
| PCT Publication Date: | April 14, 2005 | PCT Publication Number: | WO2005/032513 |
International Family Members for US Patent 7,838,027
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 045956 | ⤷ Free Forever Trial | |||
| Australia | 2004278037 | ⤷ Free Forever Trial | |||
| Brazil | PI0415014 | ⤷ Free Forever Trial | |||
| Canada | 2539982 | ⤷ Free Forever Trial | |||
| China | 1886119 | ⤷ Free Forever Trial | |||
| Colombia | 5690538 | ⤷ Free Forever Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
